Tolvaptan Completed Phase 4 Trials for Cirrhosis of the Liver / Ascites Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01292304Tolvaptan for Ascites in Cirrhotic Patients